Mfg Part Number
Ab04631-34.11-BS

Vector Labs Ab04631-34.11-BS Anti-Flagellin protein [0A07], Camelid VHH, His-tagged, (1 mg)

Quick Overview
The original antibody was generated by immunizing alpacas with heat-inactivated Salmonella cells.
$5,162.30
Order will ship within 1-3 business days
Add to Wish List
Product Class:Purified
Clone ID:0A07
Heavy Chain Modification:His-tagged
Synonyms:FliC; AbiSeO7
Amount:1 mg
Application Codes Clone:ELISA; inhibition; in vitro; in vivo
Shipping Temperature:Wet Ice
Buffer Composition:PBS only.
Original Format:VHH
Storage Temperature:Store at 4⁰C for up to 3 months. Note, this antibody is provided without added preservatives, it is therefore recommed this antibody be handled under sterile conditions. For longer storage, aliquot and store at -20⁰C.
Specificity Statement:This antibody is specific for the flagellin protein (FliC) of Salmonella enterica, which plays a pivotal role in bacterial motility and pathogenicity. FliC is the main structural component of the bacterial flagella in Salmonella enterica, tail-like structures essential for bacterial movement and invasion of host tissues. Targeting FliC can potentially neutralize the pathogen by hindering its motility, thus preventing its invasion of host cells. Additionally, antibodies against FliC may facilitate bacterial recognition and elimination by the host immune system, aiding in the clearance of the bacteria from the body.
Application Notes:The original version of this antibody (alpaca VHH) exhibited the highest inhibition of intracellular S. enterica (strain Hadar 5643) growth out of all of the tested antibodies. In vitro, the antibody was evaluated for its ability to disrupt Salmonella colonization in chicken intestinal cultures, resulting in a significant 7.5-log reduction in Salmonella genome copy numbers in ileum sections. In vivo, it was tested for its protective efficacy in broiler chickens challenged with Salmonella enterica via oral gavage. The antibody significantly decreased Salmonella levels by 0.7 log10 in both jejunum and ileum compared to the control group when administered at three different time points post-challenge (US10421806B2).
More Information
Brand Vector Labs
UNSPSC 12161500